Sunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortium

Bolek, H.Kuzu, O.F.Sertesen Camoz, E.Sim, S.Sekmek, S.Karakas, H.Urun, Y.2025-02-252025-02-2520252523-3548https://doi.org/10.1002/cac2.70003https://hdl.handle.net/20.500.14365/5947eninfo:eu-repo/semantics/openAccessSunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer ConsortiumLetter10.1002/cac2.700032-s2.0-85217359773